Weekly paclitaxel/carboplatin and radiotherapy in inoperable squamous cell carcinoma of head & neck and lung

被引：0
|
作者：
Schmidt, P [1 ]
Heck, HK [1 ]
Preiss, J [1 ]
机构：
[1] CARITAS CLIN ST THERESIA,DEPT HAEMATOL & ONCOL,SAARBRUCKEN,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：874 / 874
页数：1
相关论文
共 50 条
  • [31] INTEGRATION OF CHEMOTHERAPY IN AN MFD RADIOTHERAPY PLAN FOR ADVANCED INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    CORVO, R
    MERLANO, M
    LOONEY, WB
    BENASSO, M
    BACIGALUPO, A
    MARGARINO, G
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1990, 12 (01): : 60 - 68
  • [32] Postoperative Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
    Mendenhall, William M.
    Hinerman, Russell W.
    Amdur, Robert J.
    Malyapa, Robert S.
    Lansford, Christopher D.
    Werning, John W.
    Villaret, Douglas B.
    CLINICAL MEDICINE & RESEARCH, 2006, 4 (03) : 200 - 208
  • [33] CAPRA: Safety, efficacy, and translational biomarkers of weekly everolimus, carboplatin, and paclitaxel as induction therapy for locally advanced head and neck squamous cell carcinoma (HNSCC)
    Raymond, Eric
    Le Tourneau, Christophe
    Gatineau, Michel
    Delord, Jean-Pierre
    Fayette, Jerome
    Dreyer, Chantal
    Tijeras-Raballand, Annemilai
    Albert, Sebastien
    Granier, Muriel
    Chibaudel, Benoist
    Hadengue, Alexandra
    Aissat, Nasredine
    Slimane, Khemaies
    Faivre, Sandrine J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Quality of life of elderly patients receiving weekly carboplatin and paclitaxel chemotherapy plus cetuximab first line for metastatic squamous cell carcinoma of the head and neck
    Lugini, A.
    Rossi, R.
    Pace, R.
    Rauco, A.
    Santarelli, M.
    Capparella, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S752 - S752
  • [35] Phase II trial of carboplatin/paclitaxel and cetuximab, followed by carboplatin/paclitaxel/cetuximab and erlotinib, in metastatic or recurrent squamous cell carcinoma of the head and neck.
    Bhatia, Aarti K.
    Mehra, Ranee
    Khan, Saad A.
    Egleston, Brian L.
    Alpaugh, R. Katherine
    Lango, Miriam
    Ridge, John A.
    Burtness, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] FEASIBILITY AND PHARMACOKINETICS OF PACLITAXEL, CARBOPLATIN, AND CONCURRENT RADIOTHERAPY FOR REGIONALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK AND FOR REGIONALLY ADVANCED NON-SMALL-CELL LUNG-CANCER
    AISNER, J
    BELANI, CP
    KEARNS, C
    CONLEY, B
    HIPONIA, D
    ENGSTROM, C
    ZUHOWSKI, E
    EGORIN, MJ
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 17 - 21
  • [37] Weekly cisplatin concurrently with radiotherapy in head and neck squamous cell carcinoma: A retrospective analysis of a tertiary institute
    Elamin, Y. Y.
    Ebrahem, H.
    Flynn, A.
    O'Regan, E.
    Brennan, S.
    Osman, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S752 - S752
  • [38] Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck
    Fujii M.
    Tsukuda M.
    Satake B.
    Kubota A.
    Kida A.
    Kohno N.
    Okami K.
    Inuyama Y.
    International Journal of Clinical Oncology, 2004, 9 (2) : 107 - 112
  • [39] Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin
    Jaglowski, Jeffrey R.
    Stack, Brendan C., Jr.
    CANCER LETTERS, 2006, 243 (01) : 58 - 63
  • [40] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    CANCER, 2001, 91 (07) : 1316 - 1323
12345